Coronavirus (COVID-19)

If you have been in close contact with a person who recently tested positive for COVID-19, if you have symptoms (fever, cough and/or shortness of breath), or have recently traveled to or from an infected area, you should reach out to your physician, or any other healthcare provider, to be tested.

COVID-19 IgG/IgM ANTIBODY TESTING - Available Now!

Learn More

URINARY TRACT INFECTION (UTI) PANEL MOLECULAR TEST PANEL •

Real-Time Polymerase Chain Reaction
• Identifies of 17 pathogens from a single specimen
• Identifies bacteria regardless of recent antibiotic use
• Identifies difficult to culture pathogens
• Offers simplicity and convenience of single specimen collection
• Yields > 95% analytical sensitivity and specificit

Learn More

Laboratory Test Directory

Zika Virus Assays Authorized for Emergency Use

2016-08-26 06:00:00

On February 26, 2016, Sylvia Burwell, Secretary of Health and Human Services (HHS), decided that Zika virus had significant potential to cause a public health emergency that might affect national security or the health and security of United States citizens living abroad. The Secretary of HHS then declared that circumstances existed to justify authorization of the emergency use of in vitro diagnostics for detection of Zika virus and/or diagnosis of Zika virus infection.

Since that time, FDA has issued an Emergency Use Authorization (EUA) for the emergency use of seven different assays for the qualitative detection of RNA from Zika virus in human serum, plasma, urine. The seven molecular assays and their approval dates are listed below:

xMAP multiflex Zika RNA Assay (Luminex), August 4, 2016
Versant Zika RNA 1.0 Assay (kPCR) kit (Siemens Healthcare Diagnostics Inc), July 29, 2016
Viracor-IBT Laboratories, Inc. Zika Virus Real-time RT-PCR test , July 19, 2016
Aptima Zika Virus Assay (Hologic, Inc), July 17, 2016
RealStar Zika Virus RT-PCR kit U.S. (Altona Diagnostics), May 13, 2016
Zika Virus RNA Qualitative Real-Time RT-PCR (Focus Diagnostics), April 28, 2016
Zika MAC-ELISA (CDC), February 26, 2016
Trioplex Real-time RT-PCR assay (CDC), March 17, 2016

These assays can be used by laboratories in the United States that are certified under CLIA 1988 to perform high complexity tests or similarly qualified non-U.S. laboratories. The Viracor test is limited to testing in their own facility. Testing should be limited to detection of Zika virus in specimens collected from individuals meeting the Centers for Disease Control and Prevention's clinical criteria and/or epidemiological criteria for Zika virus infection.

FDA has also issued an EUA for the CDC’s Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) for the presumptive detection of Zika virus-specific IgM in human sera or cerebrospinal fluid. Testing can be performed by qualified laboratories designated by CDC and certified by CLIA 1988.

Reference:

http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm

Coronavirus (COVID-19)

Prostate Health Index (phi)™

URINARY TRACT INFECTION (UTI) PANEL MOLECULAR TEST PANEL •

xTAG® Gastrointestinal Pathogen Panel (GPP)

Laboratory Test Directory

Login

For Clinician Providers

Test Categories

For Patients

Zika Virus Assays Authorized for Emergency Use

Find a Location

Sign in

Laboratory Test Directory

Login

For Clinician Providers

Test Categories

For Patients

Zika Virus Assays Authorized for Emergency Use

Find a Location